- Home
- CRVS vs PML Comparison
CRVS vs PML Comparison
Compare CRVS & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- PML
- Stock Information
- Founded
- CRVS 2014
- PML 2002
- Country
- CRVS United States
- PML United States
- Employees
- CRVS N/A
- PML N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- PML Investment Managers
- Sector
- CRVS Health Care
- PML Finance
- Exchange
- CRVS Nasdaq
- PML Nasdaq
- Market Cap
- CRVS 459.0M
- PML 478.0M
- IPO Year
- CRVS 2016
- PML N/A
- Fundamental
- Price
- CRVS $7.00
- PML $7.93
- Analyst Decision
- CRVS Strong Buy
- PML
- Analyst Count
- CRVS 3
- PML 0
- Target Price
- CRVS $13.00
- PML N/A
- AVG Volume (30 Days)
- CRVS 789.4K
- PML 188.0K
- Earning Date
- CRVS 11-11-2025
- PML 01-01-0001
- Dividend Yield
- CRVS N/A
- PML 5.65%
- EPS Growth
- CRVS N/A
- PML N/A
- EPS
- CRVS N/A
- PML N/A
- Revenue
- CRVS N/A
- PML N/A
- Revenue This Year
- CRVS N/A
- PML N/A
- Revenue Next Year
- CRVS N/A
- PML N/A
- P/E Ratio
- CRVS N/A
- PML N/A
- Revenue Growth
- CRVS N/A
- PML N/A
- 52 Week Low
- CRVS $2.54
- PML $6.92
- 52 Week High
- CRVS $10.00
- PML $9.46
- Technical
- Relative Strength Index (RSI)
- CRVS 58.81
- PML 66.86
- Support Level
- CRVS $6.65
- PML $7.79
- Resistance Level
- CRVS $7.39
- PML $7.79
- Average True Range (ATR)
- CRVS 0.42
- PML 0.07
- MACD
- CRVS -0.04
- PML -0.01
- Stochastic Oscillator
- CRVS 55.47
- PML 57.14
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About PML Pimco Municipal Income Fund II of Beneficial Interest
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.